KNSA

Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals International PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KNSA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/26	05 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/09/24	06 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/09/05	09 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/09/05	09 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/09/05	09 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/09/05	09 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/08/29	05 : 01	GlobeNewswire Inc.	Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/24	05 : 39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/24	05 : 38	Edgar (US Regulatory)	Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/24	05 : 38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/23	20 : 54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/23	20 : 30	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/17	05 : 01	GlobeNewswire Inc.	Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/07/09	21 : 00	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/06/24	21 : 00	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/06/17	21 : 30	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/06/15	05 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/06/06	05 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/06/05	05 : 01	GlobeNewswire Inc.	Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/05/30	06 : 19	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/05/08	05 : 01	GlobeNewswire Inc.	Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/04/23	20 : 30	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/04/17	05 : 01	GlobeNewswire Inc.	Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/04/02	20 : 30	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/03/06	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/03/06	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/03/02	07 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/03/01	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/02/28	21 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC
2024/02/28	21 : 30	GlobeNewswire Inc.	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	NASDAQ:KNSA	Kiniksa Pharmaceuticals International PLC